» Articles » PMID: 2276737

Localization of the Von Hippel-Lindau Disease Gene to a Small Region of Chromosome 3

Overview
Journal Genomics
Specialty Genetics
Date 1990 Dec 1
PMID 2276737
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

We studied 25 families with von Hippel-Lindau disease (VHL) to locate VHL more precisely on chromosome 3. We found that VHL was linked to RAF1, confirming previous observations, and to two polymorphic DNA markers, D3S18 and D3S191. Multipoint linkage analysis indicated that the most likely location for VHL was in the interval between RAF1 and D3S18. D3S18 was located at 3p26. Genetic heterogeneity was not detected in this panel of von Hippel-Lindau disease families. The polymorphic markers RAF1, D3S18, and D3S191 should be useful in identifying asymptomatic gene carriers in VHL families and in guiding efforts at gene isolation.

Citing Articles

Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy.

Stampone E, Bencivenga D, Capellupo M, Roberti D, Tartaglione I, Perrotta S Cell Mol Life Sci. 2023; 80(8):220.

PMID: 37477829 PMC: 10361942. DOI: 10.1007/s00018-023-04852-2.


Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors.

Crabtree J Front Oncol. 2022; 12:901435.

PMID: 35747820 PMC: 9209739. DOI: 10.3389/fonc.2022.901435.


The von Hippel-Lindau Tumor Suppressor Gene: Implications and Therapeutic Opportunities.

Elias R, Zhang Q, Brugarolas J Cancer J. 2020; 26(5):390-398.

PMID: 32947307 PMC: 9812266. DOI: 10.1097/PPO.0000000000000480.


Next Generation Sequencing in Renal Cell Carcinoma: Towards Precision Medicine.

Elias R, Sharma A, Singla N, Brugarolas J Kidney Cancer J. 2020; 17(4):94-104.

PMID: 32206160 PMC: 7089604.


Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma.

Bielecka Z, Czarnecka A, Szczylik C Front Oncol. 2014; 4:194.

PMID: 25120953 PMC: 4110478. DOI: 10.3389/fonc.2014.00194.